Artificial intelligence adoption in pharma isn’t failing because of technology — it’s stalling because leadership behaviors and operating...
Partnership brings together enterprise data infrastructure, advanced analytics, and organizational strategy and execution under a unified solution [Fort...
The symptoms are easy to recognize. The account team meeting that nobody prepares for. The MSL who learns...
AI transformation in biopharma isn’t primarily a technology challenge—it’s a human capital one. This article outlines how roles,...
Culture transformation isn’t a messaging exercise—it’s a behavior change system. This retrospective explores what actually shifts mindsets, how...
Artificial intelligence adoption in pharma isn’t failing because of technology — it’s stalling because leadership behaviors and operating...
The 5C’s in Practice: What Successful Pharma Transformations Have in Common Seventy percent of large-scale change initiatives fail...
Commercial model redesigns have accelerated as customers consolidate and decision‑making shifts to system‑level stakeholders. New strategic account roles...
As 2026 begins, pharmaceutical leaders face significant industry changes, including pricing pressures and evolving customer expectations. Effective strategic...
“We always spend December planning,” a biotech COO told us, “but when January arrives, we’re still in meetings...
As 2025 wraps up, many organizations rush to close the books — but few pause to consider what...
As we close out 2025 and look ahead to a new year, leaders have an opportunity to reflect...
As pharmaceutical account teams race to close out the year, Q4 often exposes breakdowns in collaboration, coordination, and...
As Q4 2025 approaches, commercial leaders in life sciences face a landscape defined by complexity, not just innovation....
The most successful pharmaceutical organizations do not rely on a few exceptional leaders at the top—they systematically develop...
“Next – Transforming Learning Together,” the theme of LTEN 2025, captured the urgency and energy of an industry...
In today’s rapidly evolving pharmaceutical landscape, transformation isn’t optional — it’s essential. As new therapies emerge, the demand...